Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s98, 2020. DOI: 10.25251/skin.4.supp.98. Disponível em: https://skin.dermsquared.com/skin/article/view/1068. Acesso em: 2 may. 2026.